Immuron to present at LD Micro Main Event
Proactive Investors
Published Oct 04, 2023 13:30
Updated Oct 04, 2023 14:00
Immuron to present at LD Micro Main Event
Immuron Ltd (NASDAQ:IMRN, ASX:IMC) CEO Steven Lydeamore will be presenting at the 16th annual LD Micro Main Event on Wednesday, October 4th at 11:00 PT at the Luxe Sunset Boulevard Hotel in Los Angeles.
The Australian based and globally integrated biopharmaceutical company today released the presentation slides that Lydeamore will be presenting at the prominent three-day investor conference.
Included are anticipated key milestones that the company expects to drive value, including progressing to clinical trials for Travelan, CampETEC and IMM-529.
Immunron is a Melbourne based biopharmaceutical company focused on developing and commercialising orally delivered targeted polyclonal antibodies for the treatment of infectious diseases.
Its Travelan product is an orally administered passive immunotherapy that prophylactically reduces the likelihood of contracting travellers’ diarrhoea, a digestive tract disorder commonly caused by pathogenic bacteria and the toxins they produce.
Read more on Proactive Investors AU
Disclaimer
Get The App
Written By: Proactive Investors
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.